A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06046729 · COMPLETED
Trial details
- NCT number
- NCT06046729
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2025-09-30
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.